zimberelimab,domvanalimab
gilead,otsuka,arcus biosciences
['domvana', 'zimberelimab']
#asco23 | hall a | mon 8am ct
(1/2) star-221: a randomized, open-label, multicenter, phase 3 trial of domvanalimab, zimberelimab, and chemotherapy versus... 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.